134 related articles for article (PubMed ID: 12186527)
21. [TNFα blocking agents and sarcoidosis: an update].
Toussirot E; Pertuiset E
Rev Med Interne; 2010 Dec; 31(12):828-37. PubMed ID: 20510487
[TBL] [Abstract][Full Text] [Related]
22. Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice.
Lorentzen AO; Sveberg L; Midtvedt Ø; Kerty E; Heuser K
Clin Neuropharmacol; 2014; 37(5):142-8. PubMed ID: 25229171
[TBL] [Abstract][Full Text] [Related]
23. The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy.
Crouser ED; Lozanski G; Fox CC; Hauswirth DW; Raveendran R; Julian MW
Chest; 2010 Jun; 137(6):1432-5. PubMed ID: 20525654
[TBL] [Abstract][Full Text] [Related]
24. Infliximab for refractory sarcoidosis.
Baughman RP; Lower EE
Sarcoidosis Vasc Diffuse Lung Dis; 2001 Mar; 18(1):70-4. PubMed ID: 11354550
[TBL] [Abstract][Full Text] [Related]
25. Treatment of refractory neurosarcoidosis with Infliximab.
Santos E; Shaunak S; Renowden S; Scolding NJ
J Neurol Neurosurg Psychiatry; 2010 Mar; 81(3):241-6. PubMed ID: 18977810
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab.
Crommelin HA; van der Burg LM; Vorselaars AD; Drent M; van Moorsel CH; Rijkers GT; Deneer VH; Grutters JC
Respir Med; 2016 Jun; 115():72-7. PubMed ID: 27215507
[TBL] [Abstract][Full Text] [Related]
27. Optic neuropathy in refractory neurosarcoidosis treated with TNF-alpha antagonist.
Salama B; Gicquel JJ; Lenoble P; Dighiero PL
Can J Ophthalmol; 2006 Dec; 41(6):766-8. PubMed ID: 17224962
[TBL] [Abstract][Full Text] [Related]
28. Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab.
Ahmed MM; Mubashir E; Dossabhoy NR
Clin Rheumatol; 2007 Aug; 26(8):1346-9. PubMed ID: 16850114
[TBL] [Abstract][Full Text] [Related]
29. Cardiac sarcoidosis responding to monotherapy with infliximab.
Uthman I; Touma Z; Khoury M
Clin Rheumatol; 2007 Nov; 26(11):2001-3. PubMed ID: 17394036
[TBL] [Abstract][Full Text] [Related]
30. Anti-TNF therapeutics for the treatment of sarcoidosis.
Crommelin HA; Vorselaars AD; van Moorsel CH; Korenromp IH; Deneer VH; Grutters JC
Immunotherapy; 2014; 6(10):1127-43. PubMed ID: 25428650
[TBL] [Abstract][Full Text] [Related]
31. [Sarcoidosis: changing insights in therapy].
Kamphuis LS; van Laar JA; Kuijpers RW; Missotten T; Thio HB; van Hagen PM
Ned Tijdschr Geneeskd; 2010; 154(47):A1685. PubMed ID: 21118599
[TBL] [Abstract][Full Text] [Related]
32. Up-to-date in pulmonary and extrapulmonary sarcoidosis.
Valeyre D; Uzunhan Y; Bouvry D; Naccache JM; Nunes H
Acta Clin Belg; 2008; 63(6):408-13. PubMed ID: 19170359
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor alpha blockade as therapy for sarcoidosis: comment on the article by Ulbricht et al.
Lee AS; Utz JP; Specks U
Arthritis Rheum; 2004 Aug; 50(8):2717-8; author reply 2718-9. PubMed ID: 15334498
[No Abstract] [Full Text] [Related]
34. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists.
Thielen AM; Barde C; Saurat JH; Laffitte E
Dermatology; 2009; 219(1):59-62. PubMed ID: 19468200
[TBL] [Abstract][Full Text] [Related]
35. Treatment of refractory sarcoidal parotid gland swelling in a previously reported unresponsive case.
Mandel L; Wolinsky B; Chalom EC
J Am Dent Assoc; 2005 Sep; 136(9):1282-5. PubMed ID: 16196234
[TBL] [Abstract][Full Text] [Related]
36. Treatment of sarcoidosis: grading the evidence.
James WE; Baughman R
Expert Rev Clin Pharmacol; 2018 Jul; 11(7):677-687. PubMed ID: 29883224
[TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia from sarcoidosis successfully treated with infliximab.
Huffstutter JG; Huffstutter JE
Sarcoidosis Vasc Diffuse Lung Dis; 2012 Mar; 29(1):51-2. PubMed ID: 23311123
[TBL] [Abstract][Full Text] [Related]
38. Refractory neurosarcoidosis responsive to infliximab.
Kobylecki C; Shaunak S
Pract Neurol; 2007 Apr; 7(2):112-5. PubMed ID: 17430876
[No Abstract] [Full Text] [Related]
39. [Successful treatment with infliximab of a patient with refractory sarcoidosis].
Fouchier SM; Möller GM; Van Santen-Hoeufft M; Faber CG; Smeenk FW; Drent M
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2446-50. PubMed ID: 15626311
[TBL] [Abstract][Full Text] [Related]
40. Refractory retinal vasculitis due to sarcoidosis successfully treated with infliximab.
Cruz BA; Reis DD; Araujo CA;
Rheumatol Int; 2007 Oct; 27(12):1181-3. PubMed ID: 17520259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
